| 中文名 | 3-氰基-5-[[3,5-二乙基-1-(2-羟基乙基)-1H-吡唑-4-基]氧基]苯腈 |
|---|---|
| 英文名 | 5-[3,5-diethyl-1-(2-hydroxyethyl)pyrazol-4-yl]oxybenzene-1,3-dicarbonitrile |
| 中文别名 | 5-((3,5-二乙基-1-(2-羟乙基)-1H-吡唑-4-基)氧基)间苯二甲腈 |
| 英文别名 |
Lersivirine (UK-453061) ,S8055
3-Cyano-5-[[3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yl]oxy]benzonitrile ZZE Lersivirine [USAN:INN] 3-CYANO-5-[[3,5-DIETHYL-1-(2-HYDROXYETHYL)-1H-PYRAZOL-4-YL]OXY]BENZONITRILE 5-[3,5-DIETHYL-1-(2-HYDROXYETHYL)PYRAZOL-4-YL]OXYBENZENE-1,3-DICBONITRILE 1,3-Benzenedicbonitrile, 5-[[3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yl]oxy] Lersivirine, 10 mM in DMSO HIV,non-nucleoside reverse transcription,Reverse Transcriptase,HIV virus,UK 453061,Inhibitor,Lersivirine,UK453061,Human immunodeficiency virus,inhibit,resistant strain,NNRTI,NNRTI-resistant 5-((3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yl)oxy)isophthalonitrile 5-{[3,5-Diethyl-1-(2-Hydroxyethyl)-1h-Pyrazol-4-Yl]oxy}benzene-1,3-Dicarbonitrile 5-{[3,5-Diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yl]oxy}isophthalonitrile 2won 5-((3,5-Diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4- yl)oxy)benzene-1,3-dicarbonitrile UK 453061; UK453061 [14C]-Lersivirine |
| 描述 | Lersivirine(UK-453061)是非核苷逆转录酶抑制剂(NNRTI),IC50为119 nM,对野生型和NNRTI抗性型毒株都有效。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 密度 | 1.2±0.1 g/cm3 |
|---|---|
| 沸点 | 455.4±45.0 °C at 760 mmHg |
| 分子式 | C17H18N4O2 |
| 分子量 | 310.350 |
| 闪点 | 229.2±28.7 °C |
| 精确质量 | 310.142975 |
| PSA | 94.86000 |
| LogP | 3.30 |
| 蒸汽压 | 0.0±1.2 mmHg at 25°C |
| 折射率 | 1.595 |
| 储存条件 | 2-8℃ |
|
~70%
473921-12-9 |
| 文献:Bioorganic and Medicinal Chemistry Letters, , vol. 19, # 20 p. 5857 - 5860 |
| 上游产品 1 | |
|---|---|
| 下游产品 0 | |